Recent whistleblower allegations have rocked the Biden administration, claiming that billions of taxpayer dollars were misused by a government contractor involved in child trafficking operations at the U.S.-Mexico border. The …
-
-
Recent research has shown that Wegovy and Ozempic, two popular weight-loss drugs, may reduce the risk of several obesity-related cancers. The findings, published in the July 5 issue of JAMA …
-
President Joe Biden’s health has come under scrutiny following revelations that a renowned neurologist specializing in Parkinson’s disease has made multiple visits to the White House. According to visitor logs, …
-
A record-breaking heat wave is relentlessly sweeping across the United States, leading to unprecedented temperatures, health emergencies, and intensified wildfire conditions. An excessive heat warning, the National Weather Service’s most …
-
ormer President Donald Trump has gained a significant lead over President Joe Biden in crucial battleground states, according to a recent Emerson/DemNextGen poll. The poll, conducted between June 30 and …
-
The cost of purchasing a new home in the United States has reached an all-time high, creating an affordability challenge for many Americans. According to the latest data from Redfin, …
-
America NowElection 2024
GOP-led House Panel to Question Psaki on Failures of Afghanistan Withdrawal This Month
Former White House Press Secretary Jen Psaki has agreed to sit down with the House Foreign Affairs Committee this month to discuss the Biden administration’s tumultuous withdrawal from Afghanistan. This …
-
Tanja Benton, a former biostatistical research scientist at BlueCross BlueShield of Tennessee (BCBST), has been awarded nearly $700,000 by a federal jury after being fired for refusing a COVID-19 vaccine …
-
The U.S. Food and Drug Administration (FDA) announced on Tuesday that it will ban the use of brominated vegetable oil (BVO) in food items, effective August 2, citing safety concerns. …
-
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …